Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Frank Buttgereit, J. W. J. Bijlsma et al.|Annals of the Rheumatic Diseases|2016Cited by 331
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesRobert Knobler, Thomas Krieg, Elisabeth Aberer et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 261
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human MacrophagesStefano Soldano, Maurizio Cutolo|PLoS ONE|2016Cited by 68
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)Luisella Cianferotti, Maria Luisa Brandi, Francesco Bertoldo et al.|Endocrine|2017Cited by 68
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patientsMaurizio Cutolo, Samuele Tardito|Arthritis Research & Therapy|2021Cited by 42